🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for CNS Embryonal Tumor

Key Longitudinal Associations With Risk and Glioblastoma Outcomes NCT06625684n/a1 site📍 Durham Duke University A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion NCT04655404EARLY Phase 121 sites📍 Aurora📍 Washington D.C.📍 Chicago Nationwide Children's Hospital · Tests: Larotrectinib, Larotrectinib surgical An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites📍 Beijing📍 Zhengzhou📍 Hangzhou Beijing Tide Pharmaceutical Co., Ltd · Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures NCT07493447EARLY Phase 11 site📍 Nashville Eben Rosenthal · Tests: Panitumumab-IRDye800 NK Cell Therapy for Malignant Solid Brain Tumors NCT07552233NA4 sites📍 Beijing📍 Qinhuangdao📍 Zhengzhou Peking University Third Hospital · Tests: Autologous NK cells rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG NCT04943848Phase 13 sites📍 Orange📍 Chicago📍 Boston Ann & Robert H Lurie Children's Hospital of Chicago · Tests: rHSC-DIPGVax, Balstilimab, Zalifrelimab 18F-DOPA II - PET Imaging Optimization NCT04706910Phase 31 site📍 Edmonton University of Alberta · Tests: 18F-DOPA, Furosemide Injection AI-driven Processing and Analysis of Glioma Imaging Data NCT07703761n/a1 site📍 Trento Università degli Studi di Trento · Tests: AI-driven analysis of brain MRI data for early, non-invasive detection, segmentation, and histological characterization… Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors NCT00870129NA1 site📍 New York Memorial Sloan Kettering Cancer Center · Tests: MRI and advanced MRI sequences Safety and Effectiveness Evaluation of Temozolomide (Amitzo, NanoAlvand) in Patients With Grade III and IV Glioma Tumors NCT07675070n/a1 site📍 Tehran NanoAlvand · Tests: temozolomide A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients NCT06496971Phase 32 sites📍 Taipei📍 Taoyuan NaviFUS Corporation · Tests: Bevacizumab, Microbubble, Low-Intensity Focused Ultrasound Rare Embryonal Tumors of the Central Nervous System: International Registry NCT05711992n/a11 sites📍 Yerevan📍 Ottawa📍 Budapest Immune Oncology Research Institute Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology NCT04648462n/a3 sites📍 Maastricht📍 Groningen📍 Delft Maastricht Radiation Oncology · Tests: ProTRAIT Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China NCT05672043n/a1 site📍 Beijing Beijing Tiantan Hospital Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site📍 Boadilla del Monte Fundación de investigación HM · Tests: Olaparib; 177Lu-DOTATATE Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain Tumors NCT07236840n/a1 site📍 Mumbai Tata Memorial Centre · Tests: Neurological assessment Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion NCT06333899EARLY Phase 118 sites📍 Aurora📍 Washington D.C.📍 Chicago Nationwide Children's Hospital · Tests: Lorlatinib, Lorlatinib with chemotherapy1, Lorlatinib with chemotherapy 2, Lorlatinib post Radiation C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B) NCT04099797Phase 11 site📍 Houston Baylor College of Medicine · Tests: C7R-GD2.CART cells (IV and ICV infusion), C7R-GD2.CART cells (IV and ICV infusion) 000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations NCT05588141Phase 1, Phase 22 sites📍 Jacksonville📍 Bethesda National Cancer Institute (NCI) · Tests: Zotiraciclib Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and Adhesion NCT05990244NA1 site📍 Shenyang Shengjing Hospital · Tests: Magnetic Resonance Elastography, Assessment and Recording Non-invasive Glioma Characterization Through Molecular Imaging NCT03684109NA1 site📍 Miami University of Miami · Tests: 3T MRI Scanner Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma NCT07416188Phase 1, Phase 21 site📍 Bethesda National Institute of Neurological Disorders and Stroke (NI… · Tests: LMP744, Conventional Surgery or Biopsy Chronic CED of TPT for Recurrent Malignant Glioma NCT06666712Phase 11 site📍 New York Jeffrey N. Bruce · Tests: Topotecan Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease NCT07025226EARLY Phase 11 site📍 Rochester Mayo Clinic · Tests: Biospecimen Collection, Dasatinib, Fisetin, Magnetic Resonance Imaging, Patient Observation Engineering Immune Organoids to Study Pediatric Cancer NCT05890781NA2 sites📍 Villejuif📍 Paris Gustave Roussy, Cancer Campus, Grand Paris · Tests: Skin biopsy, Fresh tumor sample, Blood sample, Healthy tissue from the tumor, Spinal cerebrospinal fluid (SCF) USPIO Enhanced MR Imaging in CNS Tumours (UMIC) NCT06572475NA1 site📍 Salford Northern Care Alliance NHS Foundation Trust · Tests: USPIO enhanced MRI Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases NCT06888817Phase 36 sites📍 Amsterdam📍 Amsterdam📍 Leiden The Netherlands Cancer Institute · Tests: Bevacizumab, Dexamethasone Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors NCT05982691n/a1 site📍 Goyang-si National Cancer Center, Korea · Tests: Radiation Therapy Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus NCT02479698Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Allogeneic BK-specific Cytotoxic T-lymphocytes, Laboratory Biomarker Analysis Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation NCT07076498Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: M032
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy